Skip to main content
OpenTrials

Clinical trial condition

Adrenal Cortex Diseases

Explore clinical trials studying Adrenal Cortex Diseases. Study availability and eligibility vary by location and protocol.

96 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Adrenal Cortex Diseases trial results

Completed

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

NCT01262235

Conditions
ACC, Adenocarcinoma, Adrenal Cortex Diseases, +26 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details
Completed

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

NCT00215202

Conditions
Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +6 more
Locations
  • Kentuckiana Cancer Institute PLLC Louisville, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma

NCT01898715

Conditions
ACC, Adenocarcinoma, Adrenal Cancer, +12 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • National Institutes of Health/National Cancer Institute Bethesda, Maryland, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • MDAnderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

NCT01514526

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations
  • Complejo Hospitalario Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Universitario Fundación de Alcorcón Alcorcón, Madrid, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Universitario Reina Sofía Córdoba, Spain
View Trial Details
Completed

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

NCT00445718

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +13 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 45 locations
View Trial Details
Completed

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

NCT02150213

Conditions
Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +23 more
Locations
  • Novartis Investigative Site Tallahassee, Florida, United States
  • Novartis Investigative Site Baltimore, Maryland, United States
  • Novartis Investigative Site Hoffman, New Jersey, United States
  • Novartis Investigative Site Dallas, Texas, United States
View all 20 locations
View Trial Details
Completed

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

NCT00094497

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +11 more
Locations
  • National Cancer Institute - Center for Cancer Research Bethesda, Maryland, United States
  • University of Michigan, Department of Internal Medicine Ann Arbor, Michigan, United States
  • Royal Adelaide Hospital Adelaide, Australia
  • University of Graz Graz, Austria
View all 32 locations
View Trial Details

Related conditions